[Gene therapy for primary immunodeficiency diseases].
Ariga
Tadashi
T
Department of Pediatrics, Hokkaido University Graduate School of Medicine.
D048868:Adaptor Proteins, Signal Transducing; D000243:Adenosine Deaminase / Q000172:deficiency; D002066:Busulfan / Q000627:therapeutic use; D004268:DNA-Binding Proteins / Q000235:genetics / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods / Q000639:trends; D005822:Genetic Vectors; D006105:Granulomatous Disease, Chronic / Q000628:therapy; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D060588:LIM Domain Proteins; D008667:Metalloproteins / Q000235:genetics / Q000627:therapeutic use; D011518:Proto-Oncogene Proteins; D012190:Retroviridae; D016511:Severe Combined Immunodeficiency / Q000628:therapy
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins; D000243:Adenosine Deaminase; D002066:Busulfan